P3-086: Initial safety results from expended access program (EAP) with erlotinib in non small cell lung cancer (NSCLC) in Israel
2007
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI